Tuesday, July 28, 2015 9:54:56 AM
"NNVC shareholders seem unaware of this incriminating must-read document, written by a company insider and supporter, which outlines countless examples and allegations of NNVC managers Seymour and Diwan abusing shareholders and looting the company."
"First, NNVC does not own any of the intellectual property or patents under development by NNVC. 100% of NNVC's research, development and "technology" relies on licenses on the IP from Theracour. As a result, NNVC is literally nothing without the "Theracour Pharma, Inc" relationship."
"Diwan and Eugene seem to have deliberately used NNVC's cash to develop drugs for the benefit of Diwan's Theracour to which NNVC had no rights."
"Theracour can gouge NNVC for an arbitrarily decided "30% of direct cost" additional fee? As Diwan is 70% owner of Theracour, 70% of this money is his and how much cash he has received is not explained in the SEC filings."
"There is no excuse for a public company with more than a few million dollars to not be using a reputable big 4 auditor. NNVC shareholders should demand this to ensure their financial statements are reliable."
"Where is the truly independent analysis? Where are the big pharma companies knocking down their door with huge cash payments for exclusive research contracts like BIND?"
"NNVC shareholders are fed a steady diet of "imminent news," promises and promotion that never materialize into anything meaningful like this absurd 2009 press release about agreement with unnamed "Major Pharma" that turned out to be nothing."
"We estimate NNVC has only performed testing on ~5k animals which makes the ~$20m "spent" on R&D over the past 7 years also very questionable."
"We think NNVC should trade for less than cash given egregious dilution and cash burn (biotechs often trade for less than cash for these reasons) but even applying a generous premium to NNVC gives a per share value of less than $1 or -82% downside."
http://seekingalpha.com/article/2010691-nanoviricides-house-of-cards-with-minus-80-percent-downside-strong-sell-recommendation
The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM